Elevated serum alpha fetoprotein levels promote pathological progression of hepatocellular carcinoma

doi:10.3748/wjg.v17.i41.4563

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 41

This Article

(0)

(9910)

(48)

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Original Article

World J Gastroenterol. Nov 7, 2011; 17(41): 4563-4571
Published online Nov 7, 2011. doi: 10.3748/wjg.v17.i41.4563

Table 1 Clinical features of hepatocellular carcinoma patient cohort (n = 160) (mean ± SD)

	Concentration of AFP (μg/L)
	< 20	20-250	≥ 250
Age (yr)	51.6 ± 9.9	54.6 ± 10.3	51.2 ± 9.8
Sex (male/female)	56/12	29/7	43 /13
ALT (U/L)	58.0 ± 60.0	55.8 ± 48.2	58.7 ± 58.5
Child
A	52	0	47
B	12	5	7
C	4	1	2
HBsAg (+)	56	28	50
HCV (+)	1	1	1
Non-viral	11	7	5

AFP: Alpha fetoprotein; ALT: Alanine transaminase; HBsAg(+): Hepatitis B virus antigen positive; HCV: Hepatitis C virus; Non-viral: Non-viral etiology.

Full Size Table

Citation: Li P, Wang SS, Liu H, Li N, McNutt MA, Li G, Ding HG. Elevated serum alpha fetoprotein levels promote pathological progression of hepatocellular carcinoma. World J Gastroenterol 2011; 17(41): 4563-4571
URL: https://www.wjgnet.com/1007-9327/full/v17/i41/4563.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i41.4563

Li P, Wang SS, Liu H, Li N, McNutt MA, Li G, Ding HG. Elevated serum alpha fetoprotein levels promote pathological progression of hepatocellular carcinoma. World J Gastroenterol 2011; 17(41): 4563-4571 [PMID: 22147961 DOI: 10.3748/wjg.v17.i41.4563]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.